Leptospira interrogans serovar Grippotyphosa antigens (L. interrogans serovar Grippotyphosa antigens)

Leptospira interrogans serovar Grippotyphosa antigens are molecular components, such as outer membrane proteins and lipopolysaccharides, derived from this specific spirochete strain (PubMed: 11526074). These antigens are primarily used as immunogens in vaccines to prevent leptospirosis, a zoonotic disease affecting humans and a wide range of animals, including dogs and cattle (CDC). The biological function of these antigens in the pathogen involves mediating host cell attachment and facilitating immune evasion during the early stages of infection (PubMed: 15731209). In a clinical setting, the antigens are the targets of the host's adaptive immune response, leading to the production of agglutinating antibodies (WHO). Vaccines containing these antigens, such as multi-valent leptospiral bacterins, work by priming the immune system to recognize the Grippotyphosa serovar specifically (Merck Veterinary Manual). Because immunity to Leptospira is largely serovar-specific, these antigens are essential for providing protection against the renal and hepatic failure often associated with this particular strain (NIH). Diagnostic assays like the Microscopic Agglutination Test (MAT) utilize these antigens to detect and quantify specific antibodies in patient serum (CDC). Safety concerns associated with these antigens include the risk of acute hypersensitivity reactions and the challenge of providing broad-spectrum protection across the diverse Leptospira genus.

Other names

Grippotyphosa antigensLeptospira interrogans serogroup Grippotyphosa

Stimulation of active immunity and production of serovar-specific neutralizing antibodies